Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Deerfield Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Deerfield Management

Deerfield Management

Operating

NY-based Deerfield Management, a leading global investment firm specializing in healthcare and biotech sectors.

Location
New York City, NY, US
Founded
1994
Firm
Compare
Portfolio
Fundraising
Employees
Website

Deerfield Management is a prominent investment firm based in New York City, specializing in the healthcare and biotechnology sectors. The firm provides flexible funding models across various stages, including Series A, B, C, and beyond, as well as post-IPO equity and debt financing. Deerfield's investments typically range from early-stage to late-stage rounds, supporting companies throughout the healthcare ecosystem.

Notable portfolio companies include Arvinas, CytomX Therapeutics, and Exelixis. Deerfield offers a comprehensive infrastructure of support through initiatives like Cure, its innovation campus, and Deerfield Discovery & Development. The firm is led by key partners with extensive industry experience, enhancing its ability to drive advancements in healthcare and biotechnology.

Deerfield Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments161
Current Portfolio Count121
Total Portfolio Exits5

Top Investment Stages

Series A32 (28.8%)
Series C26 (23.4%)
Series B20 (18.0%)
Series Unknown20 (18.0%)
Post Ipo Equity13 (11.7%)

Stage Mix

Series A 29%Series C 23%Series B 18%Series Unknown 18%Post Ipo Equity 12%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Cohere Health logo

Cohere Health

Bicara Therapeutics logo

Bicara Therapeutics

Adela logo

Adela

Actio Biosciences logo

Actio Biosciences

Octave Bioscience logo

Octave Bioscience

Presidio Medical logo

Presidio Medical

Bitterroot Bio logo

Bitterroot Bio

Cortica logo

Cortica

Perceive Biotherapeutics logo

Perceive Biotherapeutics

Fog Pharmaceuticals logo

Fog Pharmaceuticals

Abeona Therapeutics logo

Abeona Therapeutics

Intus Care logo

Intus Care

Cota Healthcare logo

Cota Healthcare

Sientra logo

Sientra

Pleno logo

Pleno

Innervace logo

Innervace

SpringWorks Therapeutics logo

SpringWorks Therapeutics

Insilico Medicine logo

Insilico Medicine

Vicinitas Therapeutics logo

Vicinitas Therapeutics

Humanity Health logo

Humanity Health

Epic Sciences logo

Epic Sciences

UTR Therapeutics logo

UTR Therapeutics

Acutus Medical logo

Acutus Medical

Apertura Gene Therapy logo

Apertura Gene Therapy

Aurion Biotech logo

Aurion Biotech

Deerfield Management - Similar Investment Firms

Deerfield Partners logo

Deerfield Partners

deerfieldteam.com

Deerfield Capital Management logo

Deerfield Capital Management

Petrichor Healthcare Capital Management logo

Petrichor Healthcare Capital Management

petrichorcap.com

OrbiMed Advisors logo

OrbiMed Advisors

orbimed.com

Deer Park Road logo

Deer Park Road

deerparkrd.com

Foresite Capital logo

Foresite Capital

Driehaus Capital Management logo

Driehaus Capital Management

driehaus.com

Partner Fund Management logo

Partner Fund Management

White Deer Management logo

White Deer Management

Davidson Kempner Capital Management logo

Davidson Kempner Capital Management

Newpath Management logo

Newpath Management

newpath.partners

Global BioAccess Fund logo

Global BioAccess Fund

Decheng Capital logo

Decheng Capital

decheng.com

Madison Dearborn Partners logo

Madison Dearborn Partners

mdcp.com

Meyer Global Management logo

Meyer Global Management

Deerfield Management - Classification

Also Known As
  • Deerfield Management Company, L.P.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified